Validity and Reliability of Value Assessment Frameworks for New Cancer Drugs

Several organizations have developed frameworks to systematically assess the value of new drugs. These organizations include the American Society of Clinical Oncology (ASCO), the European Society for Medical Oncology (ESMO), the Institute for Clinical and Economic Review (ICER), and the National Com...

Full description

Saved in:

Bibliographic Details
Published in:	Value in health Vol. 20; no. 2; pp. 200 - 205
Main Authors:	Bentley, Tanya G.K., Cohen, Joshua T., Elkin, Elena B., Huynh, Julie, Mukherjea, Arnab, Neville, Thanh H., Mei, Matthew, Copher, Ronda, Knoth, Russell, Popescu, Ioana, Lee, Jackie, Zambrano, Jenelle M., Broder, Michael S.
Format:	Journal Article
Language:	English
Published:	United States Elsevier Inc 01.02.2017 Elsevier Science Ltd
Subjects:	Antineoplastic Agents - standards Cancer Confidence intervals Convergent validity Decision making Decision Support Techniques Drugs Evaluation Feedback Health care inter-rater reliability Internal Medicine Lung cancer Medical decision making Medical Oncology Oncology Pilot Projects Reliability Reproducibility of Results Sensitivity analysis Validity Value value frameworks Value-Based Purchasing convergent validity value frameworks oncology inter-rater reliability
ISSN:	1098-3015, 1524-4733, 1524-4733
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!